Literature DB >> 18691676

Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition.

Padmini S Kedar1, Donna F Stefanick, Julie K Horton, Samuel H Wilson.   

Abstract

Inhibition of PARP activity results in extreme sensitization to MMS-induced cell killing in cultured mouse fibroblasts. In these MMS-treated cells, PARP inhibition is accompanied by an accumulation of S-phase cells that requires signaling by the checkpoint kinase ATR [J.K. Horton, D.F. Stefanick, J.M. Naron, P.S. Kedar, S.H. Wilson, Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest following DNA methylating agent exposure, J. Biol. Chem. 280 (2005) 15773-15785]. Here, we examined mouse fibroblast extracts for formation of a complex that may reflect association between the damage responsive proteins PARP-1 and ATR. Co-immunoprecipitation of PARP-1 and ATR was observed in extracts prepared from MMS-treated cells, but not under conditions of PARP inhibition. Further, our experiments demonstrated PAR-adduction of ATR in extracts from control and MMS-treated cells. An interaction between purified ATR and PARP-1 was similarly demonstrated, suggesting that the observed co-immunoprecipitation of ATR and PARP-1 from cell extracts may be due to a direct interaction between the two enzymes. In addition, purified recombinant ATR is a substrate for poly(ADP-ribosyl)ation by PARP-1, and poly(ADP-ribose) adduction of PARP-1 and ATR resulted in an increase in PARP-1 and ATR co-immunoprecipitation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691676      PMCID: PMC2585487          DOI: 10.1016/j.dnarep.2008.07.006

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  37 in total

Review 1.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

2.  Preferential binding of ATR protein to UV-damaged DNA.

Authors:  Keziban Unsal-Kaçmaz; Alexander M Makhov; Jack D Griffith; Aziz Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

3.  Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1.

Authors:  F Dantzer; G de La Rubia; J Ménissier-De Murcia; Z Hostomsky; G de Murcia; V Schreiber
Journal:  Biochemistry       Date:  2000-06-27       Impact factor: 3.162

4.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.

Authors:  L Virág; P Jagtap; E Szabó; J G Mabley; L Liaudet; A Marton; D G Hoyt; K G Murthy; A L Salzman; G J Southan; C Szabó
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

5.  Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R B Luo; R Samara; M Jung; A Dritschilo; A Spoonde; M E Smulson
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

6.  Photoaffinity labeling of mouse fibroblast enzymes by a base excision repair intermediate. Evidence for the role of poly(ADP-ribose) polymerase-1 in DNA repair.

Authors:  O I Lavrik; R Prasad; R W Sobol; J K Horton; E J Ackerman; S H Wilson
Journal:  J Biol Chem       Date:  2001-05-04       Impact factor: 5.157

7.  Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints.

Authors:  W A Cliby; C J Roberts; K A Cimprich; C M Stringer; J R Lamb; S L Schreiber; S H Friend
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

Review 8.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

9.  Hypersensitivity of DNA polymerase beta null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions.

Authors:  Julie K Horton; Donna F Joyce-Gray; Brian F Pachkowski; James A Swenberg; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2003-01-02

10.  Direct interaction between mammalian DNA polymerase beta and proliferating cell nuclear antigen.

Authors:  Padmini S Kedar; Soon-Jong Kim; Anthony Robertson; Esther Hou; Rajendra Prasad; Julie K Horton; Samuel H Wilson
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

View more
  21 in total

1.  HMGN1 protein regulates poly(ADP-ribose) polymerase-1 (PARP-1) self-PARylation in mouse fibroblasts.

Authors:  Aya Masaoka; Natalie R Gassman; Padmini S Kedar; Rajendra Prasad; Esther W Hou; Julie K Horton; Michael Bustin; Samuel H Wilson
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

2.  The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.

Authors:  David Davidson; Yunzhe Wang; Raquel Aloyz; Lawrence Panasci
Journal:  Invest New Drugs       Date:  2012-10-09       Impact factor: 3.850

3.  Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.

Authors:  Michelle L Heacock; Donna F Stefanick; Julie K Horton; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2010-06-22

4.  Infralimbic EphB2 Modulates Fear Extinction in Adolescent Rats.

Authors:  Emmanuel Cruz; Omar Soler-Cedeño; Geovanny Negrón; Marangelie Criado-Marrero; Gladys Chompré; James T Porter
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

Review 5.  Base excision repair and design of small molecule inhibitors of human DNA polymerase β.

Authors:  Samuel H Wilson; William A Beard; David D Shock; Vinod K Batra; Nisha A Cavanaugh; Rajendra Prasad; Esther W Hou; Yuan Liu; Kenjiro Asagoshi; Julie K Horton; Donna F Stefanick; Padmini S Kedar; Michael J Carrozza; Aya Masaoka; Michelle L Heacock
Journal:  Cell Mol Life Sci       Date:  2010-09-16       Impact factor: 9.261

6.  The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest.

Authors:  Dana L Madison; Daniel Stauffer; James R Lundblad
Journal:  DNA Repair (Amst)       Date:  2011-08-12

7.  An Interaction with PARP-1 and Inhibition of Parylation Contribute to Attenuation of DNA Damage Signaling by the Adenovirus E4orf4 Protein.

Authors:  Keren Nebenzahl-Sharon; Rakefet Sharf; Jana Amer; Hassan Shalata; Hanan Khoury-Haddad; Sook-Young Sohn; Nabieh Ayoub; Patrick Hearing; Tamar Kleinberger
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

8.  Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist.

Authors:  Renukadevi Patil; Erzsébet Szabó; James I Fells; Andrea Balogh; Keng G Lim; Yuko Fujiwara; Derek D Norman; Sue-Chin Lee; Louisa Balazs; Fridtjof Thomas; Shivaputra Patil; Karin Emmons-Thompson; Alyssa Boler; Jur Strobos; Shannon W McCool; C Ryan Yates; Jennifer Stabenow; Gerrald I Byrne; Duane D Miller; Gábor J Tigyi
Journal:  Chem Biol       Date:  2015-01-22

9.  HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.

Authors:  Suchitra Natarajan; Sabine Hombach-Klonisch; Peter Dröge; Thomas Klonisch
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

10.  Kinetics of poly(ADP-ribosyl)ation, but not PARP1 itself, determines the cell fate in response to DNA damage in vitro and in vivo.

Authors:  Harald Schuhwerk; Christopher Bruhn; Kanstantsin Siniuk; Wookee Min; Suheda Erener; Paulius Grigaravicius; Annika Krüger; Elena Ferrari; Tabea Zubel; David Lazaro; Shamci Monajembashi; Kirstin Kiesow; Torsten Kroll; Alexander Bürkle; Aswin Mangerich; Michael Hottiger; Zhao-Qi Wang
Journal:  Nucleic Acids Res       Date:  2017-11-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.